{"id":214,"date":"2017-01-14T18:20:38","date_gmt":"2017-01-14T18:20:38","guid":{"rendered":"http:\/\/www.haptens-antibodies.com\/?page_id=214"},"modified":"2017-03-12T09:48:37","modified_gmt":"2017-03-12T09:48:37","slug":"functionalized-derivatives-and-immunoreactive-for-fludioxonil-fungicide-2","status":"publish","type":"page","link":"http:\/\/www.haptens-antibodies.com\/en\/functionalized-derivatives-and-immunoreactive-for-fludioxonil-fungicide-2\/","title":{"rendered":"Functionalized derivatives and immunoreactive for fludioxonil fungicide"},"content":{"rendered":"<p><\/p>\n<h2 style=\"text-align: left; padding-top: 3%; border-bottom: 1px solid #e7ad4a; padding-bottom: 1%; margin-bottom: 2%;\"><span style=\"color: #e7ad4a; font-size: 18pt;\">\u2192<\/span><strong><span style=\"color: #545454;\">\u00a0Patent details <\/span><\/strong><\/h2>\n<table class=\"aligncenter\" style=\"width:80%; border-color: #e7ad4a; border-style: double;\" border=\"1\" cellpadding=\"2\">\n<tbody>\n<tr style=\"height: 24px;\">\n<th style=\"width: 100%; background-color: #29618c; height: 24px; text-align: center;\" colspan=\"2\"><span style=\"color: #ffffff; font-family: helvetica, arial, sans-serif; font-size: 11pt;\">Patent<\/span><\/th>\n<\/tr>\n<tr style=\"height: 15.7118px;\">\n<td style=\"width: 183px; height: 15.7118px; padding-left: 30px; text-align: center;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\"><strong>Title:<\/strong><\/span><\/td>\n<td style=\"width: 555px; height: 15.7118px; padding-left: 30px; text-align: left;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\">Functionalized derivatives and immunoreactive for fludioxonil fungicide<\/span><\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"width: 183px; height: 24px; padding-left: 30px; text-align: center;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\"><strong>Inventors:<\/strong><\/span><\/td>\n<td style=\"width: 555px; height: 24px; padding-left: 30px; text-align: left;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\">A. Abad Somovilla, C. Agull\u00f3 Blanes, A. Abad Fuentes, J. V. Mercader Bad\u00eda, F. A. Esteve Turrillas<\/span><\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"width: 183px; height: 24px; padding-left: 30px; text-align: center;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\"><strong>Application number:<\/strong><\/span><\/td>\n<td style=\"width: 555px; height: 24px; padding-left: 30px; text-align: left;\"><span class=\"s1\" style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\">WO2014\/060623 A1<\/span><\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"width: 183px; height: 24px; padding-left: 30px; text-align: center;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\"><strong>Priority date:<\/strong><\/span><\/td>\n<td style=\"width: 555px; height: 24px; padding-left: 30px; text-align: left;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\">16\/10\/2012<\/span><\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"width: 183px; height: 24px; padding-left: 30px; text-align: center;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\"><strong>Titular entity:<\/strong><\/span><\/td>\n<td style=\"width: 555px; height: 24px; padding-left: 30px; text-align: left;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\">Universidad de Valencia y CSIC<\/span><\/td>\n<\/tr>\n<tr style=\"height: 27px;\">\n<td style=\"width: 183px; height: 27px; padding-left: 30px; text-align: center;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\"><strong>Abstract:<\/strong><\/span><\/td>\n<td style=\"width: 555px; height: 27px; padding-left: 30px; text-align: left;\">\n<p class=\"p1\"><span class=\"s1\" style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\">The invention relates to haptenes, conjugates, marked derivates and antibodies for fludioxonil. The invention also relates to the use of conjugates of fludioxonil as test antigens or immunogens for producing antibodies of said fungicide; and to the use of the marked derivatives of fludioxonil as test antigens. The invention further relates to a method for analysing fludioxonil using the antibodies produced, sometimes together with test antigens that are conjugates or marked derivatives. The invention also provides a kit for analysing fludioxonil comprising antibodies of said fungicide, sometimes together with test antigens that are conjugates or marked derivatives.<\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 27px;\">\n<td style=\"width: 183px; height: 27px; padding-left: 30px; text-align: center; vertical-align: middle;\"><span style=\"font-family: helvetica, arial, sans-serif; font-size: 11pt;\"><strong>\u00a0Patentscope:<\/strong><\/span><\/td>\n<td style=\"width: 555px; height: 27px; padding-left: 30px; text-align: left;\"><a href=\"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2014060623\" target=\"_blank\"><img loading=\"lazy\" width=\"300\" height=\"63\" class=\"wp-image-268 aligncenter\" style=\"width: 199px; height: 42px;\" src=\"http:\/\/www.haptens-antibodies.com\/wp-content\/uploads\/2017\/01\/wipo-300x63.jpg\" alt=\"\" srcset=\"http:\/\/www.haptens-antibodies.com\/wp-content\/uploads\/2017\/01\/wipo-300x63.jpg 300w, http:\/\/www.haptens-antibodies.com\/wp-content\/uploads\/2017\/01\/wipo.jpg 531w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>\u2192\u00a0Patent details Patent Title: Functionalized derivatives and immunoreactive for fludioxonil fungicide Inventors: A. Abad Somovilla, C. Agull\u00f3 Blanes, A. Abad Fuentes, J. V. Mercader Bad\u00eda, F. A. Esteve Turrillas Application number: WO2014\/060623 A1 Priority date: 16\/10\/2012 Titular entity: Universidad de Valencia y CSIC Abstract: The invention relates to haptenes, conjugates, marked derivates and antibodies for [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"_links":{"self":[{"href":"http:\/\/www.haptens-antibodies.com\/en\/wp-json\/wp\/v2\/pages\/214"}],"collection":[{"href":"http:\/\/www.haptens-antibodies.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.haptens-antibodies.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.haptens-antibodies.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.haptens-antibodies.com\/en\/wp-json\/wp\/v2\/comments?post=214"}],"version-history":[{"count":14,"href":"http:\/\/www.haptens-antibodies.com\/en\/wp-json\/wp\/v2\/pages\/214\/revisions"}],"predecessor-version":[{"id":1146,"href":"http:\/\/www.haptens-antibodies.com\/en\/wp-json\/wp\/v2\/pages\/214\/revisions\/1146"}],"wp:attachment":[{"href":"http:\/\/www.haptens-antibodies.com\/en\/wp-json\/wp\/v2\/media?parent=214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}